These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9247157)

  • 21. Effect of inhibitory activity of mutation at reaction site P4 of the Streptomyces subtilisin inhibitor, SSI.
    Kojima S; Kumagai I; Miura K
    Protein Eng; 1990 May; 3(6):527-30. PubMed ID: 2196560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain.
    Almog O; Gallagher T; Tordova M; Hoskins J; Bryan P; Gilliland GL
    Proteins; 1998 Apr; 31(1):21-32. PubMed ID: 9552156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of deletion in the flexible loop of the protease inhibitor SSI (Streptomyces subtilisin inhibitor) on interactions with proteases.
    Kojima S; Furukubo S; Kumagai I; Miura K
    Protein Eng; 1993 Apr; 6(3):297-303. PubMed ID: 8506264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures of Streptomyces subtilisin inhibitor and its complex with subtilisin BPN'.
    Mitsui Y; Satow Y; Watanabe Y; Hirono S; Iitaka Y
    Nature; 1979 Feb; 277(5696):447-52. PubMed ID: 763329
    [No Abstract]   [Full Text] [Related]  

  • 25. A protease inhibitor produced by Streptomyces lividans 66 exhibits inhibitory activities toward both subtilisin BPN' and trypsin.
    Ueda Y; Kojima S; Tsumoto K; Takeda S; Miura K; Kumagai I
    J Biochem; 1992 Aug; 112(2):204-11. PubMed ID: 1356971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The complete amino acid substitutions at position 131 that are positively involved in cold adaptation of subtilisin BPN'.
    Taguchi S; Komada S; Momose H
    Appl Environ Microbiol; 2000 Apr; 66(4):1410-5. PubMed ID: 10742220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of propeptide as an intramolecular chaperone for in vivo folding of subtilisin nattokinase.
    Jia Y; Liu H; Bao W; Weng M; Chen W; Cai Y; Zheng Z; Zou G
    FEBS Lett; 2010 Dec; 584(23):4789-96. PubMed ID: 21074529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of a tyrosyl residue and carboxyl groups in the specific interaction between Streptomyces subtilisin inhibitor and subtilisin BPN'. A chemical modification study.
    Inouye K; Tonomura B; Hiromi K
    J Biochem; 1979 May; 85(5):1115-26. PubMed ID: 447612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity.
    Brode PF; Erwin CR; Rauch DS; Barnett BL; Armpriester JM; Wang ES; Rubingh DN
    Biochemistry; 1996 Mar; 35(10):3162-9. PubMed ID: 8605150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folding of subtilisin BPN': characterization of a folding intermediate.
    Eder J; Rheinnecker M; Fersht AR
    Biochemistry; 1993 Jan; 32(1):18-26. PubMed ID: 8418836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action.
    Kojima S; Kumagai I; Miura K
    J Mol Biol; 1993 Mar; 230(2):395-9. PubMed ID: 8464055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular recognition at the active site of subtilisin BPN': crystallographic studies using genetically engineered proteinaceous inhibitor SSI (Streptomyces subtilisin inhibitor).
    Takeuchi Y; Noguchi S; Satow Y; Kojima S; Kumagai I; Miura K; Nakamura KT; Mitsui Y
    Protein Eng; 1991 Jun; 4(5):501-8. PubMed ID: 1891457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
    Hiraga K; Suzuki T; Oda K
    J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The refined crystal structure of subtilisin Carlsberg at 2.5 A resolution.
    Neidhart DJ; Petsko GA
    Protein Eng; 1988 Oct; 2(4):271-6. PubMed ID: 3150541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The determination of molecular weights of Streptomyces subtilisin inhibitor and the complex of Streptomyces subtilisin inhibitor and subtilisin BPN' by sedimentation equilibrium.
    Inouye K; Tonomura B; Hiromi K; Kotaka T; Inagaki H; Sato S; Murao S
    J Biochem; 1978 Oct; 84(4):843-53. PubMed ID: 711701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stoichiometry of the interaction of human plasma alpha 1-proteinase inhibitor with subtilisin BPN'.
    Abe O; Kuromizu K
    J Biochem; 1989 Jan; 105(1):66-71. PubMed ID: 2661553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal denaturation of streptomyces subtilisin inhibitor, subtilisin BPN', and the inhibitor-subtilisin complex.
    Takahashi K; Sturtevant JM
    Biochemistry; 1981 Oct; 20(21):6185-90. PubMed ID: 7030385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.